Navigation Links
Array BioPharma Announces Management Team Change
Date:11/21/2013

BOULDER, Colo., Nov. 21, 2013 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY) announced today that Kevin Koch, Ph.D., President and Chief Scientific Officer, will be leaving Array to pursue other opportunities.

(Photo: http://photos.prnewswire.com/prnh/20121029/LA02195LOGO)

"The board and executive team thank Dr. Koch for his leadership and contributions to the success of Array over the past 15 years.  During this time, Array advanced 19 novel compounds into clinical trials, of which 14 remain in active development," said Ron Squarer, Chief Executive Officer of Array.  "With several of these programs in late stage trials, and a strong management team in place, Array is well-positioned for continued success."

Array remains committed to its world-class discovery organization and its existing research partnerships.

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.  Seven Phase 3 or pivotal studies are already in progress, or are planned to begin, within the next year. These programs include the wholly-owned hematology drug, ARRY-520, for multiple myeloma and two partnered cancer drugs, selumetinib (AstraZeneca) and MEK162 (Novartis).  For more information on Array, please go to www.arraybiopharma.com

CONTACT:

Array BioPharma


Tricia Haugeto, (303) 386-1193


thaugeto@arraybiopharma.com


'/>"/>
SOURCE Array BioPharma
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Array BioPharma To Present At The Jefferies 2013 Global Healthcare And Piper Jaffray 25th Annual Healthcare Conferences
2. Array BioPharma To Present Clinical Data At The 2013 ASH Annual Meeting On ARRY-520 For Multiple Myeloma And ARRY-614 For Myelodysplastic Syndromes
3. ARRAYit Corporation Receives Purchase Order from ChemBio
4. Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2014 And Announces ARRY-520 Development Strategy
5. Array BioPharma To Report Financial Results For The First Quarter Of Fiscal 2014 On October 31, 2013
6. Arrayit Corporation Announces New Corporate Headquarters in Sunnyvale California
7. ARRAYit Corporation Receives $104,000 Purchase Order from the University of California
8. ARRAYit Corporation Ships Proprietary Life Sciences Products to Google Inc.
9. ARRAYit Corporation Ships Proprietary Life Sciences Products to Illumina Inc.
10. Gentris Corporation Launches Next Generation Human Transcriptome Array
11. Genentech Purchases Arrayit Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... DENVER , March 23, 2017  Drug ... pain medication misuse and deadly overdoses. A new ... Health Solutions, www.cordantsolutions.com , reports more detailed ... tests, which can potentially improve therapy adherence, patient ... The Cordant Comprehensive Oral fluid Rx Evaluation ...
(Date:3/23/2017)... , March 23, 2017  A new genetic ... accurate identification of individuals who carry HLA-B*15:02 ... a rare yet potentially deadly side effect of ... disorder.  The gene HLA-B*15:02 is strongly ... as Stevens-Johnson syndrome and toxic epidermal necrolysis in ...
(Date:3/23/2017)... ALBANY, New York , March 23, 2017 ... devices market exhibits a consolidated vendor landscape with the ... the overall market in 2015. These companies are ... Industries, Inc., Hygia Health Services, Inc., and VANGUARD ... global reprocessed medical devices market is witnessing the ...
Breaking Medicine Technology:
(Date:3/23/2017)... Virginia (PRWEB) , ... March 23, 2017 , ... ... public health services to their communities, 16 more public health departments have been ... week’s decisions bring another 4.5 million people into the expanding network of communities ...
(Date:3/23/2017)... , ... March 23, 2017 , ... 82% of adults are unaware of the dangers ... not brush their teeth the minimum two times a day that dentists recommend. The ramifications ... 51 million hours of school and adults missing 164 million hours of work each year ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... ... investment in Los Angeles based healthcare technology company California Healthcom Group (CHG). ... the US, and healthcare arena. With headquarters in California, CHG is a growing, ...
(Date:3/23/2017)... ... ... After raising more than $1.135 million ($1,479,231 AUD) from nearly 20,000 backers ... crowdfunding history, has established a U.S. Headquarters in New York City, FaceCradle USA, LLC, ... excited to be operating on U.S. shores, where most of our initial crowdfunding backers ...
(Date:3/23/2017)... ... ... According to the National Sleep Foundation , poor sleep quality affects ... of the sunken-eye look, which can include dark circles or bags under the eyes. ... likely due to genetics, dehydration, allergies, and losing fat beneath the thin skin under ...
Breaking Medicine News(10 mins):